Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00450450 · OUTCOME

Infused Nucleated and CD34+ Cell Doses

Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases · Source last updated 2022-04-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
Up to 10 years

What was measured

Compared using the Wilcoxon rank-sum test.

Analysis population: Data are not collected for this study.

Groups in this outcome

Control BM Arm

Conventional bone marrow transplant (BM)

Experimental G-BM Arm

G-CSF (filgrastim) stimulated bone marrow (G-BM)

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Control BM Arm0
Experimental G-BM Arm0

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
denoms
  1. counts
    1. group Id
      OG000
      value
      0
    2. group Id
      OG001
      value
      0
    units
    Participants
description
Compared using the Wilcoxon rank-sum test.
groups
  1. description
    Conventional bone marrow transplant (BM)
    id
    OG000
    title
    Control BM Arm
  2. description
    G-CSF (filgrastim) stimulated bone marrow (G-BM)
    id
    OG001
    title
    Experimental G-BM Arm
population Description
Data are not collected for this study.
reporting Status
POSTED
time Frame
Up to 10 years
title
Infused Nucleated and CD34+ Cell Doses
type
OTHER_PRE_SPECIFIED

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice